Most Recent
Teva, Boehringer settle inhaler capsule patent dispute
Intellectual Property 2019-06-19 2:56 pm By Miklos Bolza

Israeli drug giant Teva and German drug maker Boehringer Ingelheim have settled their dispute over a patented capsule used to deliver the medicine in Boehringer’s top-selling inhaler Spiriva.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Bayer faces appeals of IP Australia rulings on antiseptic patent
Intellectual Property 2019-06-04 3:24 pm By Miklos Bolza

Veterinary pharmaceutical companies Norbrook Laboratories and Merial have launched twin appeals of two IP Australia decisions allowing Bayer to amend a proposed patent for a treatment for mammary gland infections.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis patent for oral form of top-selling MS drug obvious, IP Australia says
Intellectual Property 2019-05-13 12:31 pm By Miklos Bolza

A proposed Novartis patent for an oral form of its top-selling multiple sclerosis drug Gilenya is invalid for lack of inventive step, IP Australia has found, but gave the pharmaceutical giant a chance to amend.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

  1. Pages:
  3. 1
  4. 2
  5. 3
  6. 4
  7. 5
  8. 6
  9. 7
  10. 8
  11. 9